Boston Scientific’s next move

With the purchase of Lumenis’s surgical laser business for $1.1bn on Wednesday and a $925m pounce on the cardiac monitoring group Preventice in January, Boston Scientific is very much following its plan to acquire high-growth companies to dig itself out of the hole Covid-19 put it in.